Schubert & CO Immunity Bio, Inc. Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$1.35 - $4.78 $8 - $28	-6 Reduced 54.55%	5 $0
Q4 2022 Jan 31, 2023	BUY	$4.35 - $6.77 $47 - $74	11 New	11 $0
Q2 2022 Aug 01, 2022	SELL	$2.68 - $6.14 $21 - $49	-8 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.05 - $7.53 $25 - $37	5 Added 166.67%	8 $0
Q4 2021 Jan 28, 2022	BUY	$5.67 - $10.18 $17 - $30	3 New	3 $0

229

82.3M

1.02M

2.25M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.1B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.